NCT04608513View on ClinicalTrials.gov

A Placebo-controlled Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

September 20, 2021

Study Completion Date

September 20, 2021

Conditions
Healthy
Interventions
DRUG

ACT-1014-6470

Soft capsules for oral administration

DRUG

Placebo

Soft capsules for oral administration

Trial Locations (1)

14050

Parexel International GmbH Klinikum Westend, Berlin

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY

NCT04608513 - A Placebo-controlled Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects | Biotech Hunter | Biotech Hunter